Teladoc Health Reviews Metformin
Core to the chronic-care model, which predates the weight-management line and covers diabetes management at national scale.
Sold as Glucophage · Reviewed September 19, 2026
What “First-line” means here
Prescribed as a first-line option. No lower-cost trial is required before a member can start.
The pairing
How Teladoc Health handles Metformin
These are the vendor-specific mechanics that determine what this molecule actually costs you and whether members stay on it long enough to benefit.
- Access status
- First-line
- Gating
- Standard clinical indication.
- Prescribes directly
- Yes
- Step therapy
- Yes
- Prior authorization
- Yes
- Titration protocol
- Configurable to employer policy; defaults to conservative escalation
- Off-ramp
- Chronic-care management continues after weight targets are met
- Care team
- Physicians, Nurse practitioners, Certified diabetes educators, Coaches
Ask Teladoc Health this
How does the weight-management programme coordinate with your existing diabetes management for a member on both? Confirm it is one care team, not two.
Watch out
Bundled pricing obscures what you actually pay for weight management. Demand the standalone line item before comparing.
The molecule
Metformin in one page
Not a GLP-1, and not a weight-loss drug — but the first rung of nearly every credible step-therapy protocol, and effectively free. How a vendor uses metformin tells you whether its cost discipline is real.
Clinical profile
- Drug class
- Biguanide
- Brand names
- Glucophage — Type 2 diabetes
- Mechanism
- Reduces hepatic glucose production and improves insulin sensitivity. Weight effect is modest and secondary to the glycemic effect.
- Administration
- Oral, daily, usually with an extended-release formulation to improve tolerability.
- Titration
- Gradual escalation over several weeks, primarily to manage gastrointestinal tolerability.
- Typical result
- Modest weight reduction — typically low single digits as a percentage — alongside meaningful glycemic improvement in appropriate patients.
- Generic available
- Yes
Known side effects
- Gastrointestinal effects, substantially reduced by extended-release formulations
- Long-term B12 depletion warranting periodic monitoring
- Lactic acidosis, rare and largely confined to renal impairment
What benefits teams need to know
A useful test of vendor honesty
Every vendor lists metformin. Far fewer can show you what share of their population is maintained on it without escalating. Ask for that number — it separates vendors with a step-therapy protocol from vendors with a step-therapy slide.
It does not compete with GLP-1s on weight
Metformin is not an alternative to incretin therapy for a member who needs substantial reduction. Its role is identifying the members who never needed the expensive drug, not substituting for it in those who do.
Alternatives
Other vendors and Metformin
Same molecule, materially different access rules. The status column is where the cost difference lives.
| Vendor | Access | Score | PMPM |
|---|---|---|---|
| Virta Health Metabolic specialist | First-line | 8.7 | $40–$95 |
| Form Health Full-service clinical | Adjunct | 8.0 | $58–$105 |
| Twin Health Metabolic specialist | First-line | 7.8 | $55–$120 |
| Found Full-service clinical | First-line | 7.6 | $45–$85 |
| Vida Health Full-service clinical | First-line | 7.5 | $38–$78 |
| 9amHealth Metabolic specialist | First-line | 7.3 | $34–$72 |
Same vendor
Teladoc Health across the formulary
How this vendor positions each molecule tells you more about its cost discipline than any single review does.
Available first-line, but the decisive feature is that eligibility and step-therapy rules are employer-configurable. Your policy governs access here, not Teladoc's clinical defaults — which is the strongest argument for buying it.
Same configurable posture as semaglutide. For a large employer running multiple point solutions, uniform policy enforcement across both molecules is worth more than any individual clinical feature.
Part of the broader chronic-care formulary and usable as a configured step-therapy rung, though it is not the default pathway.